CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 112 enrolled
Drug / intervention
Smart Speaker Echo Dot +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05329376
NCT05329376N/ACompleted

Interactive Virtual Assistance for Self-Care Management and Mental Health Promotion in Type 2 Diabetes

Pontificia Universidade Católica do Rio Grande do Sul·interventional·Posted Apr 15, 2022·Updated May 22, 2024

In Brief

A clinical study evaluating Smart Speaker Echo Dot and Usual Care for Diabetes Mellitus, Type 2 and 3 related conditions. Completed, enrolled 112 participants across 1 site.

Detailed Summary

BACKGROUD: Health technology is an important tool in the aging process, which may improve the health condition and self-esteem of the elderly, in addition to offering new opportunities and challenges. In this scenario, the use of virtual interaction systems emerge as promising alternatives for the old adults, which often deals with the lack of social interaction, cognitive decline and decline in functional capacity, making the control of chronic diseases, such as diabetes, a challenge. OBJECTIVES: This project aims to evaluate the effectiveness of using an interactive virtual assistance system in mental health parameters, glycemic profile and diabetes selfcare behavior in elderly people with diabetes. METHODS: A randomized clinical trial is proposed, for an intervention that includes 3 months of use of the Smart Speaker Echo Dot system, programmed to provide reminders, stimulate treatment records and maintain healthy habits. Outcomes assessed will include parameters of mental health and diabetes control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBrazil
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedApr 15, 2022
Enrollment StartJun 20, 2023
Primary CompletionMay 17, 2024
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 4.2 years ago

Interventions

Smart Speaker Echo Dotdevice

Participants will receive the Smart Speaker EchoDot 3rd Gen (Amazon Echo®) device (i.e., Alexa) for home use, installed during a home visit following the study enrollment. In addition to the usual functionality of the system, the device will be programmed using a standard model developed by the research team, applied to each patient. The proposed model involves automatic interactions between the device and the patient, comprising: 1. Medication reminders 2. Glucose test reminders: 3. Educational health tips 4. Weekly educational podcasts 5. Good morning and good night routine

Usual Careother

Participants will maintain usual care during the study period and will receive a booklet with general advice following enrollment